Efficacy and harms of remdesivir for the treatment of COVID-19: a systematic review and meta-analysis
View ORCID ProfileAlejandro Piscoya, View ORCID ProfileLuis Fernando Ng-Sueng, View ORCID ProfileAngela Parra del Riego, View ORCID ProfileRenato Cerna-Viacava, View ORCID ProfileVinay Pasupuleti, View ORCID ProfileYuani M. Roman, View ORCID ProfilePriyaleela Thota, View ORCID ProfileC. Michael White, View ORCID ProfileAdrian V. Hernandez
doi: https://doi.org/10.1101/2020.05.26.20109595
Alejandro Piscoya
1Unidad de Revisiones Sistemáticas y Meta-análisis (URSIGET), Vicerrectorado de Investigación, Universidad San Ignacio de Loyola (USIL), Lima, Peru (Piscoya, Ng-Sueng, Hernandez);
2Hospital Guillermo Kaelin de La Fuente, Lima, Peru (Piscoya);
Luis Fernando Ng-Sueng
1Unidad de Revisiones Sistemáticas y Meta-análisis (URSIGET), Vicerrectorado de Investigación, Universidad San Ignacio de Loyola (USIL), Lima, Peru (Piscoya, Ng-Sueng, Hernandez);
Angela Parra del Riego
3Escuela de Medicina, Universidad Peruana de Ciencias Aplicadas (UPC), Lima, Peru (Parra del Riego, Cerna-Viacava);
Renato Cerna-Viacava
3Escuela de Medicina, Universidad Peruana de Ciencias Aplicadas (UPC), Lima, Peru (Parra del Riego, Cerna-Viacava);
Vinay Pasupuleti
4MedErgy Health Group Inc., Yardley, PA (Pasupuleti);
Yuani M. Roman
5Health Outcomes, Policy, and Evidence Synthesis (HOPES) Group, University of Connecticut School of Pharmacy, Storrs, CT (Roman, White, Hernandez);
Priyaleela Thota
6Hemex Health Inc., Portland, OR (Thota)
C. Michael White
5Health Outcomes, Policy, and Evidence Synthesis (HOPES) Group, University of Connecticut School of Pharmacy, Storrs, CT (Roman, White, Hernandez);
Adrian V. Hernandez
1Unidad de Revisiones Sistemáticas y Meta-análisis (URSIGET), Vicerrectorado de Investigación, Universidad San Ignacio de Loyola (USIL), Lima, Peru (Piscoya, Ng-Sueng, Hernandez);
5Health Outcomes, Policy, and Evidence Synthesis (HOPES) Group, University of Connecticut School of Pharmacy, Storrs, CT (Roman, White, Hernandez);

Article usage
Posted May 27, 2020.
Efficacy and harms of remdesivir for the treatment of COVID-19: a systematic review and meta-analysis
Alejandro Piscoya, Luis Fernando Ng-Sueng, Angela Parra del Riego, Renato Cerna-Viacava, Vinay Pasupuleti, Yuani M. Roman, Priyaleela Thota, C. Michael White, Adrian V. Hernandez
medRxiv 2020.05.26.20109595; doi: https://doi.org/10.1101/2020.05.26.20109595
Efficacy and harms of remdesivir for the treatment of COVID-19: a systematic review and meta-analysis
Alejandro Piscoya, Luis Fernando Ng-Sueng, Angela Parra del Riego, Renato Cerna-Viacava, Vinay Pasupuleti, Yuani M. Roman, Priyaleela Thota, C. Michael White, Adrian V. Hernandez
medRxiv 2020.05.26.20109595; doi: https://doi.org/10.1101/2020.05.26.20109595
Subject Area
Subject Areas
- Addiction Medicine (76)
- Allergy and Immunology (194)
- Anesthesia (54)
- Cardiovascular Medicine (488)
- Dermatology (56)
- Emergency Medicine (168)
- Epidemiology (5661)
- Gastroenterology (215)
- Geriatric Medicine (88)
- Health Economics (229)
- Health Informatics (759)
- Health Policy (388)
- Hematology (105)
- HIV/AIDS (181)
- Medical Education (116)
- Medical Ethics (28)
- Nephrology (90)
- Neurology (845)
- Nursing (44)
- Nutrition (141)
- Oncology (514)
- Ophthalmology (162)
- Orthopedics (44)
- Otolaryngology (105)
- Pain Medicine (47)
- Palliative Medicine (21)
- Pathology (149)
- Pediatrics (248)
- Primary Care Research (113)
- Public and Global Health (2222)
- Radiology and Imaging (375)
- Respiratory Medicine (311)
- Rheumatology (109)
- Sports Medicine (82)
- Surgery (118)
- Toxicology (25)
- Transplantation (34)
- Urology (42)